Stereotaxis, Inc. (NYSEAMERICAN:STXS) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. grew its position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 10.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 167,297 shares of the company’s stock after purchasing an additional 15,491 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Stereotaxis were worth $341,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of STXS. Bank of New York Mellon Corp boosted its holdings in shares of Stereotaxis by 247.5% during the second quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock worth $345,000 after purchasing an additional 135,041 shares during the last quarter. Forum Financial Management LP acquired a new stake in Stereotaxis in the 2nd quarter worth about $48,000. Rhumbline Advisers grew its holdings in Stereotaxis by 645.6% in the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after buying an additional 41,780 shares during the period. Renaissance Technologies LLC increased its stake in shares of Stereotaxis by 46.2% during the 2nd quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after acquiring an additional 154,400 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of Stereotaxis during the 3rd quarter worth about $39,000. 45.35% of the stock is currently owned by hedge funds and other institutional investors.

Stereotaxis Stock Performance

STXS opened at $2.22 on Friday. Stereotaxis, Inc. has a 1 year low of $1.66 and a 1 year high of $3.29. The company has a market capitalization of $188.10 million, a P/E ratio of -7.93 and a beta of 1.57.

Stereotaxis (NYSEAMERICAN:STXS) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. The company had revenue of $9.20 million during the quarter, compared to analyst estimates of $6.80 million. As a group, equities research analysts anticipate that Stereotaxis, Inc. will post -0.26 EPS for the current year.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.